BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE 8 mg/1 (BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE TABLET) 8 mg/1

Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate 8 mg/1 is a sublingual tablet used for opioid dependence treatment. This combination medication helps manage withdrawal symptoms and cravings.

Strength

8 mg/1

Pack Size

30 TABLET in 1 BOTTLE, PLASTIC (16729-550-10)

Manufacturer / TM Owner

Accord Healthcare, Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate 8 mg/1 is primarily used to treat opioid dependence. It works by reducing withdrawal symptoms and cravings, helping individuals manage their recovery. This medication is often prescribed as part of a comprehensive treatment plan that includes counseling and support.

Side Effects

Common effects of Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate 8 mg/1 may include nausea, vomiting, headache, and constipation. Some users might experience dizziness or drowsiness. These effects can vary from person to person.

Precautions & Warnings

Handle Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate 8 mg/1 with care, as it is intended for sublingual use only. Store it in a safe place away from children and pets. Follow the prescribed dosage and administration instructions provided by your healthcare professional.

Avoid Interactions

Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate 8 mg/1 may interact with other medications, including alcohol, sedatives, and certain antidepressants. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.

Frequently Asked Questions

It is used to treat opioid dependence by reducing withdrawal symptoms and cravings.

This medication is designed for sublingual use, meaning it should be placed under the tongue and allowed to dissolve.

Common side effects may include nausea, vomiting, headache, and constipation.

It may interact with other medications, so it's important to consult your healthcare provider before combining it with other drugs.

Store it in a safe place away from children and pets, following the storage instructions provided.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.